MDS clinical diagnostic criteria for Parkinson's disease.
about
The biomarkers of immune dysregulation and inflammation response in Parkinson diseaseToward precision medicine in Parkinson's diseaseOptimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's diseaseUsefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PREDIGT scoreEpidemiology of Parkinson's disease.Global, Yet Incomplete Overview of Cohort Studies in Parkinson's disease.Non-motor symptoms and quality of life in subjects with mild parkinsonian signs.Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease.Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementiaAbnormal Temporal Coupling of Tactile Perception and Motor Action in Parkinson's Disease.Validation of the Parkinson Fatigue Scale in Chinese Parkinson's disease patients.Extra-striatal Uptake of 99mTc-TRODAT-1 in Meningioma Detected on SPECT/CT: Diagnostic Clue or Mere Coincidence?Embryonic development of selectively vulnerable neurons in Parkinson's disease.Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.MDS research criteria for prodromal Parkinson's disease.The Relationship between Parkinson Disease and Brain Tumor: A Meta-Analysis.Meta-analysis on the prevalence of REM sleep behavior disorder symptoms in Parkinson's diseaseSide effects induced by the acute levodopa challenge in Parkinson's Disease and atypical parkinsonisms.A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation AnalysisIs PIGD a legitimate motor subtype in Parkinson disease?Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's Disease.The Early Indicators of Functional Decrease in Mild Cognitive Impairment.Structural connectivity profile of scans without evidence of dopaminergic deficit (SWEDD) patients compared to normal controls and Parkinson's disease patients.Reduced Rapid Eye Movement Density in Parkinson Disease: A Polysomnography-Based Case-Control StudyMotor Speech Apraxia in a 70-Year-Old Man with Left Dorsolateral Frontal Arachnoid Cyst: A [18F]FDG PET-CT Study.Altered Kinematics of Facial Emotion Expression and Emotion Recognition Deficits Are Unrelated in Parkinson's Disease.Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.Mutation Analysis of HTRA2 Gene in Chinese Familial Essential Tremor and Familial Parkinson's Disease.Narrative Organization Deficit in Lewy Body Disorders Is Related to Alzheimer Pathology.Family Functioning and Communication in Spouses of Patients with Parkinsonism.The Synucleinopathies: Twenty Years On.Alterations of p11 in brain tissue and peripheral blood leukocytes in Parkinson's disease.Pseudohypoparathyroidism with basal ganglia calcification: A case report of rare cause of reversible parkinsonism.Efficacy of Servo-Controlled Splanchnic Venous Compression in the Treatment of Orthostatic Hypotension: A Randomized Comparison With Midodrine.Analysis of mitochondrial structure and function in the Drosophila larval musculature.Alterations in striato-thalamo-pallidal intrinsic functional connectivity as a prodrome of Parkinson's disease.Quality of life in Parkinson's disease patients: progression markers of mild to moderate stages.Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson's disease.Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias.
P2860
Q26738459-0419634A-9E8F-4D58-A4C3-A27C31451F6FQ26764954-DC76397C-72C4-47B8-BBC1-A1E59D82868FQ28071861-9A51CD49-22F3-43B8-8685-9677296BB381Q28553194-EF8EB5A9-FD9C-401D-B1CE-D73E52BA1876Q29048624-5A56C57F-CCAA-45A8-9E57-C54CB6793E86Q30238651-F455AE07-3982-4ADF-9D10-F18C988070AFQ30491906-C50DA94C-F87C-4852-9F40-7303D4481C39Q30572455-52F4183D-F292-4E85-8DD5-E15515BCA6F5Q33364885-1605D740-42BD-433D-8167-1D5CAC7B7E73Q33727909-5ECE3353-E001-4C46-92B1-6A3856A528B2Q33766092-88FC1C41-2DDD-4642-A327-0E10CCEA7190Q33810138-5CDFD382-5074-4469-8487-098BD53CE06AQ33827772-D5C6ECAE-8420-43B7-9D2C-C5355E0CCDFAQ33835242-FA1EA4AC-CDCE-41F7-8B40-67A9CBAE99E1Q33869820-97941028-AF44-4CBE-ACE5-28F7ED650469Q34498279-76AEB62F-DEE0-4BF6-92B6-C604B3E8405DQ36169142-C2E95620-2E36-4AD1-B915-C19DB5E870CBQ36270657-0DD192FB-5B4D-4451-B1AE-9A10B4271711Q36282655-722A4D52-3343-4308-BCC8-A805022EBBDEQ36885946-EAFBAEAD-F9F8-4899-951C-3FED787FB41FQ36966066-11CC023F-B225-4F7F-AD46-E1600883DEAAQ37053904-4D7CD9C7-0374-4157-9C1E-36C050D7430BQ37168449-5210079C-D5D8-4A01-93DE-183164A57D54Q37211642-1A0F0EEC-7E6A-4795-AA1D-3B1A4B523CC8Q37406629-12F80F5C-4451-4E57-989F-A50319753556Q37483361-A141B44B-BE5D-459A-B2CD-F3101A379B0FQ37500580-EC9DCE8F-5AB5-4086-9BBB-C53D7B954FFDQ37610726-3F66FB19-1B4D-4348-BB74-2183E45E500FQ37627534-B51E4C8D-D3D2-4EC5-85BF-F260C3114EB9Q37629836-2B4D79AB-7C9F-46B4-8E23-8DBE4A044903Q37639121-CAB3AAFF-312C-4FDB-BD2F-31BEA339FADDQ37693375-49EE652C-250F-419C-9121-8D25C2EBFC3FQ37696024-F5BA2825-2F45-45F5-9068-05E8BFAD87D1Q37725317-13E7164F-5437-465B-AEDB-6C85FAB4C2F9Q38391626-C3F61232-DCCE-41CA-A645-15CFB12EF6E6Q38413591-91F132FB-E6B7-4386-BD55-55C74A67FC87Q38601317-BE5A676C-2C91-42FF-AB96-358DA3BEBBECQ38622321-45EE04FA-7655-4EE3-869B-02CE1CC7EAFBQ38639708-18F99C9A-161B-4E06-895B-0F98B200D965Q38642389-A1CB3FE2-A8F0-49C3-B392-CFAB1AA68A06
P2860
MDS clinical diagnostic criteria for Parkinson's disease.
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
MDS clinical diagnostic criteria for Parkinson's disease.
@ast
MDS clinical diagnostic criteria for Parkinson's disease.
@en
MDS clinical diagnostic criteria for Parkinson's disease.
@nl
type
label
MDS clinical diagnostic criteria for Parkinson's disease.
@ast
MDS clinical diagnostic criteria for Parkinson's disease.
@en
MDS clinical diagnostic criteria for Parkinson's disease.
@nl
prefLabel
MDS clinical diagnostic criteria for Parkinson's disease.
@ast
MDS clinical diagnostic criteria for Parkinson's disease.
@en
MDS clinical diagnostic criteria for Parkinson's disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
MDS clinical diagnostic criteria for Parkinson's disease.
@en
P2093
José Obeso
Kenneth Marek
Matthew Stern
Ronald B Postuma
P2860
P304
P356
10.1002/MDS.26424
P407
P50
P577
2015-10-01T00:00:00Z